Doctor of Philosophy (PhD), Ohio University, 2024, Chemistry and Biochemistry (Arts and Sciences)
The human growth hormone (hGH) is a 191 amino acid polypeptide hormone synthesized
and secreted by anterior pituitary somatotrophs, that plays a pivotal role in regulating
postnatal growth, development, bone density, and metabolism. Upon secretion into
bloodstream, hGH binds to the extracellular domain of the human growth hormone
receptor (hGHR), a transmembrane protein belonging to the cytokine receptor
superfamily. Binding of hGH to the hGHR induces a conformational change in the
receptor, leading to the activation of hGHR-associated Janus kinase 2 (JAK2) in the
cytoplasm and subsequent phosphorylation of signal transducer and activator of
transcription 5 (STAT5). This phosphorylation event in turn initiates downstream
signaling pathways that regulate the expression of hGH-associated genes, such as IGF1,
FOS, SOCS2, involved in stimulating growth and regulating metabolism. Unfortunately,
dysregulated hGH signaling has been linked to various disease phenotypes, such as
acromegaly, gigantism, diabetes, cardiovascular diseases and cancer, highlighting the
therapeutic relevance of modulating hGH-hGHR interactions. To date, the only growth
hormone receptor antagonist approved by the FDA for clinical use is pegvisomant
(Somavert® for injection), which is used for the treatment of acromegaly. Although
pegvisomant has shown success in improving symptoms of acromegaly, it comes with
several disadvantages. For example, high production costs, end-product heterogeneity, and the requirement for daily injections, collectively impact efficacy of the treatment
regimen. Therefore, the development of next-generation antagonist of the hGHR has
become a necessity.
The work outlined in this dissertation addresses this gap in knowledge by
developing peptide-based antagonists that target the hGHR and aims to provide new
insight into expanding novel therapeutic strategies for growth hormone-associated
diseases.
The use of peptide-based antagonists for modulating t (open full item for complete abstract)
Committee: Justin M. Holub (Advisor)
Subjects: Biochemistry; Chemistry